Huagongshe화공사 화학 정보 인쇄 보고서 · 연구 참고용
Trifluoroacetic acid → [5-(4-Fluoro-benzenesulfonylamino)-2-propyl-benzoimidazol-1-yl]-acetic acid
참여 물질
| 역할 | 이름 | HCID | 투입량 |
|---|---|---|---|
| 반응물 | Trifluoroacetic acid | HCID 6422 | — |
| 반응물 | [5-(4-Fluoro-benzenesulfonylamino)-2-propyl-benzoimidazol-1-yl]-acetic acid tert-butyl ester | HCID 67201670 | — |
| 생성물 | [5-(4-Fluoro-benzenesulfonylamino)-2-propyl-benzoimidazol-1-yl]-acetic acid | HCID 59342517 | — |
반응 단계
The product of step d.) was treated with trifluoroacetic acid (TFA) (2 mL) for 2 hours, concentrated, and purified by preparative LCMS to give the title compound. 1H NMR (d6-DMSO) δ10.01 (br s, 1H), 7.74 (dd, J=5.3 Hz, J=8.7 Hz, 2H), 7.35 (t, J=8.7 Hz, 2H), 7.19 (d, J=1.8 Hz, 1H), 6.87 (dd, J=1.8 Hz, J=8.7 Hz, 1H), 4.93 (s, 2H), 2.67 (t, J=7.5 Hz, 2H), 1.72 (sextet, J=7.5 Hz, 2H), 0.95 (t, J=7.5 Hz, 3H). MS: ESI (negative): 390 (M−H).
출처 및 근거
| DOI | 10.6084/m9.figshare.5104873.v1 |
|---|---|
| 특허 번호 | US07732618B2 |
| 출처 데이터셋 | uspto-grants-2010_06 |
| ORD ID | ord-572c15774a1c4752bf12db44e908edab |
| 출처 메모 | uspto-grants-2010_06 |